Intervention Protocol

Chemotherapy with platinum compounds for metastatic colorectal cancer

  1. Raymond C H Ng1,*,
  2. Bernard M Fitzharris2,
  3. Phil N Hider3,
  4. Mark Jeffery4

Editorial Group: Cochrane Colorectal Cancer Group

Published Online: 8 OCT 2008

DOI: 10.1002/14651858.CD004113

Database Title

Additional Information

How to Cite

Ng RCH, Fitzharris BM, Hider PN, Jeffery M. Chemotherapy with platinum compounds for metastatic colorectal cancer (Protocol). Cochrane Database of Systematic Reviews 2003, Issue 1. Art. No.: CD004113. DOI: 10.1002/14651858.CD004113.

Author Information

  1. 1

    Unit 81, Melbourne, Australia

  2. 2

    Christchurch Hospital, Oncology Services, Christchurch, New Zealand

  3. 3

    Christchurch School of Medicine and Health Sciences, New Zealand Health Technology Assessment, Department of Public Health and General Practice, Christchurch, New Zealand

  4. 4

    Christchurch Hospital, Oncology Service, Private Bag 4710, Christchurch, New Zealand

*Raymond C H Ng, Unit 81, 1 Queensberry st, Carlton, Melbourne, VIC 3053, Australia. rayng@clear.net.nz.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 8 OCT 2008

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Full (98K)
 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The primary objective of this review is to assess the effectiveness of adding one platinum compound to other chemotherapy regimens in the first line treatment of metastatic colorectal cancer.

View Full Article (HTML) Full (98K)